How using eDiaries in Phase II can increase power while reducing subject size and costs.
Saul Shiffman
Advertisement
Articles by Saul Shiffman
Advertisement
Latest Updated Articles
Increasing Study Sensitivity in Early TrialsPublished: April 1st 2010 | Updated:
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Honing the Power of AI for Next Generation Trial Oversight and Execution
2
AstraZeneca’s Phase III POTOMAC Trial Shows Imfinzi Significantly Improves Disease-Free Survival in High-Risk NMIBC
3
ACT Brief: AI-Driven Oversight, Biotech Acceleration Strategies, and a Major Win in Bladder Cancer
4
A Look Back: AI and Pragmatic Trials Took Center Stage at SCOPE Summit 2025
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
